Table 2.
Intra-day precision analysis for absolute quantification of human UGT1A1. Two batches of pooled, individual HLMs and UGT1A1 Supersomes™ were used in the determinations (n=3).
| UGT1A1 (pmol/mg Protein) | ||||||
|---|---|---|---|---|---|---|
| Peptide 1 | Peptide 2 | |||||
| MRM1 | MRM2 | MRM1 | MRM2 | |||
| Batch 1 | pHLM | Average | 9.9 | 12.2 | 11.0 | 13.5 |
| % C.V. | 1.5 | 1.0 | 1.0 | 0.4 | ||
| Supersome™ | Average | 179.0 | 180.2 | 175.6 | 198.6 | |
| % C.V. | 3.4 | 1.6 | 1.0 | 2.0 | ||
| HLM 442 | Average | 5.6 | 8.1 | 8.6 | 9.9 | |
| % C.V. | 5.0 | 2.2 | 1.2 | 2.6 | ||
| HLM 743 | Average | 18.4 | 20.5 | 22.5 | 26.2 | |
| % C.V. | 3.7 | 4.2 | 3.3 | 5.4 | ||
| HLM 751 | Average | 18.4 | 20.8 | 20.1 | 23.9 | |
| % C.V. | 2.7 | 0.8 | 1.5 | 2.0 | ||
| Batch 2 | pHLM | Average | 8.6 | 9.0 | 3.1 | 5.1 |
| % C.V. | 4.4 | 2.0 | 3.3 | 3.8 | ||
| Supersome™ | Average | 170.0 | 176.6 | 100.4 | 111.4 | |
| % C.V. | 3.4 | 1.6 | 1.0 | 2.0 | ||
| HLM442 | Average | 4.6 | 4.8 | 1.6 | 3.1 | |
| % C.V. | 5.8 | 3.6 | 3.9 | 4.8 | ||
| HLM 743 | Average | 16.8 | 17.2 | 9.7 | 12.2 | |
| % C.V. | 3.9 | 5.0 | 4.5 | 6.6 | ||
| HLM 751 | Average | 17.5 | 18.0 | 8.6 | 11.3 | |
| % C.V. | 2.7 | 0.9 | 2.1 | 2.4 | ||